Autostat II Anti-Sm/RNP Elisa
510(k) K990624
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK990624 | Date28 Apr 1999 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LKO
- FDA applicant
- Cogent Diagnotics , Ltd.
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5100
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 23 Sep 2026
The Autostat II Anti-Sm/RNP Elisa is an in vitro diagnostic test designed for the detection of anti-Sm and anti-RNP antibodies in human serum samples. It utilizes enzyme-linked immunosorbent assay technology to aid in the diagnosis of autoimmune diseases, specifically Mixed Connective Tissue Disease.
This device is intended for use by laboratory professionals in clinical settings. It is classified as a Class 2 immunology device and has received FDA 510(k) clearance under the traditional pathway, identified by K990624.
Other devices from Cogent Diagnotics, Ltd.
Questions
AI-generated answers, 23 Sep 2026
What is the primary clinical purpose of the Autostat II Anti-Sm/RNP ELISA?
This device is an in vitro diagnostic test designed to detect anti-Sm and anti-RNP antibodies in human serum samples. It is specifically intended to aid laboratory professionals in the diagnosis of autoimmune diseases, with a focus on Mixed Connective Tissue Disease.
Who is the intended user for this diagnostic test?
The Autostat II Anti-Sm/RNP ELISA is intended for use by laboratory professionals within clinical settings. It requires professional handling to perform the enzyme-linked immunosorbent assay technology correctly and interpret the results.
What is the regulatory status of this device?
The Autostat II Anti-Sm/RNP ELISA is a Class 2 immunology device that has received FDA 510(k) clearance under the traditional pathway, identified by the K990624 submission.